Search for: "Sanofi-Aventis US, Inc."
Results 41 - 60
of 159
Sort by Relevance
|
Sort by Date
16 Feb 2014, 4:00 am
Sanofi-Aventis, et al. [read post]
17 Oct 2013, 5:00 am
Medtronic, Inc., 238 F. [read post]
3 Jan 2013, 4:00 am
Justice Snider has written in Sanofi-Aventis Canada Inc v Novopharm Ltd, 2009 FC 1139: A review of recent jurisprudence on the issue of awards in intellectual property trials indicates that this scale recognizes the significance and complexity of the various issues in such a trial. [read post]
7 Sep 2012, 3:23 pm
Allergan USA, Inc., 2012 WL 3692396 (E.D. [read post]
10 Aug 2012, 5:00 am
Sanofi-Aventis U.S. [read post]
27 Jun 2012, 9:41 am
These include cases in which the Panel concludes that the timing of the filing is to delay determination of the dispute [Sanofi-aventis v. [read post]
27 Jun 2012, 9:41 am
These include cases in which the Panel concludes that the timing of the filing is to delay determination of the dispute [Sanofi-aventis v. [read post]
27 Jun 2012, 9:41 am
These include cases in which the Panel concludes that the timing of the filing is to delay determination of the dispute [Sanofi-aventis v. [read post]
27 Jun 2012, 9:41 am
These include cases in which the Panel concludes that the timing of the filing is to delay determination of the dispute [Sanofi-aventis v. [read post]
9 Jun 2012, 5:13 am
” The former Sanofi-Aventis chemist, Yuan Li, who pled guilty in January to passing trade secrets to a Chinese company was sentenced on May 8, 2012 to 18 months in prison and ordered to pay $131,000 in restitution. [read post]
23 May 2012, 7:37 pm
Apotex, Inc. [read post]
16 May 2012, 1:49 pm
On May 7, 2012, Yuan Li, a former research scientist with Sanofi Aventis, who had pled guilty to one count of violating 18 U.S.C. [read post]
10 May 2012, 7:45 am
A Sanofi Aventis scientist has been sentenced to 18 months in prison for stealing the pharmaceutical company's trade secrets and putting them up for sale through the U.S. branch of a Chinese chemicals company. [read post]
19 Apr 2012, 10:00 pm
If there are any patent blogs you think should be highlighted by our Top 5, please comment on this post and we'll check them out. 1) CAFC Blog: Revisiting Therasense, CAFC Finds That An Inventor's Subjective Belief That Submission of Documents Was Unnecessary May Not be Sufficient to Avoid a Showing Of Intent to Deceive - This post discusses Aventis Pharma S.A. and Sanofi-Aventis U.S. [read post]
19 Apr 2012, 10:00 pm
If there are any patent blogs you think should be highlighted by our Top 5, please comment on this post and we'll check them out. 1) CAFC Blog: Revisiting Therasense, CAFC Finds That An Inventor's Subjective Belief That Submission of Documents Was Unnecessary May Not be Sufficient to Avoid a Showing Of Intent to Deceive - This post discusses Aventis Pharma S.A. and Sanofi-Aventis U.S. [read post]
22 Feb 2012, 7:37 am
GmbH and Sanofi-aventis v. [read post]
7 Feb 2012, 2:25 pm
’s (“Sandoz’s”) ANDA No. 077857 for a generic version of Sanofi-aventis U.S. [read post]
5 Feb 2012, 8:04 am
See Sanofi-Aventis chemist admits trade secret theft. [read post]
2 Dec 2011, 2:00 pm
Sanofi-Aventis United States LLC, 2011 WL 3666595, at *3 (W.D. [read post]
23 Nov 2011, 1:13 pm
Sanofi-aventis Canada Inc., in collaboration with Health Canada, would like to inform patients of important safety information related to the use of the heart drug Multaq (dronedarone).... (12/13/11) ______________________________________________________________________________ In mid-June 2011 drug regulators first turned their attention to cardiovascular side effects associated with the use of Multaq (dronedarone), soon after… [read post]